JP2014520836A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520836A5
JP2014520836A5 JP2014519611A JP2014519611A JP2014520836A5 JP 2014520836 A5 JP2014520836 A5 JP 2014520836A5 JP 2014519611 A JP2014519611 A JP 2014519611A JP 2014519611 A JP2014519611 A JP 2014519611A JP 2014520836 A5 JP2014520836 A5 JP 2014520836A5
Authority
JP
Japan
Prior art keywords
vaccine composition
nanoparticles
composition according
pseudoboehmite
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014519611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520836A (ja
JP6111245B2 (ja
Filing date
Publication date
Priority claimed from FR1156398A external-priority patent/FR2977800B1/fr
Application filed filed Critical
Publication of JP2014520836A publication Critical patent/JP2014520836A/ja
Publication of JP2014520836A5 publication Critical patent/JP2014520836A5/ja
Application granted granted Critical
Publication of JP6111245B2 publication Critical patent/JP6111245B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014519611A 2011-07-13 2012-07-12 水酸化アルミニウムナノ粒子を含むワクチン組成物 Expired - Fee Related JP6111245B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1156398 2011-07-13
FR1156398A FR2977800B1 (fr) 2011-07-13 2011-07-13 Composition vaccinale avec des nanoparticules d'hydroxyde d'aluminium
PCT/FR2012/051648 WO2013007956A1 (fr) 2011-07-13 2012-07-12 Composition vaccinale avec des nanoparticules d'hydroxyde d'aluminium

Publications (3)

Publication Number Publication Date
JP2014520836A JP2014520836A (ja) 2014-08-25
JP2014520836A5 true JP2014520836A5 (enExample) 2015-08-27
JP6111245B2 JP6111245B2 (ja) 2017-04-05

Family

ID=46639612

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014519611A Expired - Fee Related JP6111245B2 (ja) 2011-07-13 2012-07-12 水酸化アルミニウムナノ粒子を含むワクチン組成物

Country Status (9)

Country Link
US (1) US9770505B2 (enExample)
EP (1) EP2731622B1 (enExample)
JP (1) JP6111245B2 (enExample)
CN (1) CN103826658A (enExample)
CA (1) CA2838817A1 (enExample)
ES (1) ES2650740T3 (enExample)
FR (1) FR2977800B1 (enExample)
NO (1) NO2731622T3 (enExample)
WO (1) WO2013007956A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104587464B (zh) * 2015-01-23 2018-05-22 四川大学 一种基于氢氧化铝纳米粒的疫苗载体
CN106177939B (zh) * 2015-06-01 2021-01-19 普莱柯生物工程股份有限公司 一种疫苗用佐剂及其应用
CN106421775B (zh) * 2015-08-12 2020-12-01 普莱柯生物工程股份有限公司 一种疫苗用佐剂及含该佐剂的疫苗组合物和其应用
US11344491B2 (en) * 2015-09-23 2022-05-31 The Regents Of The University Of California Compositions and methods of using the same for decontamination of skin
CN107041952B (zh) * 2016-02-05 2020-11-10 中国人民解放军军事医学科学院微生物流行病研究所 表面修饰有氧化铝的疫苗及其制备方法和疫苗组合物
KR102748354B1 (ko) * 2016-06-01 2024-12-31 액세스 투 어드밴스드 헬스 인스티튜트 사이징제를 함유하는 나노명반 입자
CN113666404B (zh) * 2021-09-23 2023-07-28 北京智飞绿竹生物制药有限公司 一种适合规模化生产的高浓度纳米级氢氧化铝佐剂配制方法
CN114522241B (zh) * 2022-02-18 2024-07-05 广州瑞贝斯药业有限公司 一种铝纳米晶复合免疫药物及其制备方法和应用
GB202215072D0 (en) * 2022-10-13 2022-11-30 Glaxosmithkline Biologicals Sa Process for production of aluminium hydroxide particles
CN115944723A (zh) * 2022-12-22 2023-04-11 中国人民解放军陆军军医大学 基于纳米铝盐与纳米乳的复合物在制备疫苗佐剂中的应用及其产品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK143689C (da) * 1975-03-20 1982-03-15 J Kreuter Fremgangsmaade til fremstilling af en adsorberet vaccine
US4836948A (en) * 1987-12-30 1989-06-06 Lever Brothers Company Viscoelastic gel detergent compositions
JP3583128B2 (ja) * 1993-01-08 2004-10-27 シーエスエル、リミテッド ワクチン製剤
AU750587B2 (en) * 1998-10-16 2002-07-25 Smithkline Beecham Biologicals (Sa) Adjuvant systems and vaccines
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
CN101370515A (zh) * 2005-11-04 2009-02-18 诺华疫苗和诊断有限公司 包含颗粒佐剂和免疫增强剂组合的流感疫苗
ES2377884T3 (es) * 2005-11-04 2012-04-02 Novartis Vaccines And Diagnostics S.R.L. Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
AU2008222678B2 (en) * 2007-03-07 2013-01-17 The General Hospital Corporation Compositions and methods for the prevention and treatment of autoimmune conditions
CN105147611A (zh) * 2007-07-26 2015-12-16 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
NZ612315A (en) * 2009-04-14 2014-10-31 Novartis Ag Compositions for immunising against staphylococcus aureus

Similar Documents

Publication Publication Date Title
HK1246654A1 (zh) 具有有效表位显示的病毒样颗粒
JP2015164123A5 (enExample)
JP2016521235A5 (enExample)
MY187462A (en) Modified virus-like particles of cmv
JP2017501033A5 (enExample)
WO2015043613A8 (en) Particles comprising a shell with rna
MX2015015465A (es) Metodos para filtrar el aire.
PL3355915T3 (pl) Szczepionki zawierające cząstki wirusopodobne (VLP) parwowirusa psów (CPV) i ich zastosowania
JP2013530158A5 (enExample)
JP2012020346A5 (enExample)
JP2014509532A5 (enExample)
WO2011112008A3 (ko) 결정성 산화세륨 및 이의 제조 방법
EP3046583A4 (en) Virus-like particle conjugates for diagnosis and treatment of tumors
JP2011251901A5 (ja) スカンジア安定化ジルコニア焼結粉末およびその製造方法
MX373884B (es) Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
JP2013520167A5 (enExample)
JP2016530205A5 (enExample)
JP2017528591A5 (enExample)
CN106796835A8 (zh) 具有不同磁性质的区域的磁体以及用于形成这种磁体的方法
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
IL238223B (en) Nanoparticle mhc antigen complex, method for preparation and composition containing it
JP2016527890A5 (enExample)
JP2015522683A5 (enExample)
WO2017103600A8 (en) Preparation of respirable zafirlukast particles
JP2022529672A5 (enExample)